No it's consistent. The prospects for Ariad's drugs in the future have never been better. Therefore Denner will be less inclined to sell the company now, knowing that it will be worth much more later. The shorts know that and don't feel a great need to cover right away and have time to continue to manipulate the sp. It is totally consistent imo.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.